Thrombo-inflammation Biomarkers Trial in Acute Cerebral Hypoxia (RADICAL)
Thrombo-inflammation Biomarkers Trial in Acute Cerebral Hypoxia. A Case-control Trial Nested in a Cohort
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild
This observational or N/A phase trial investigates Cerebral Hypoxia and Ischemic Stroke and is currently actively recruiting participants. Fondation Ophtalmologique Adolphe de Rothschild leads this study, which shows 13 recorded versions since 2024 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Feb 2026 — Present [monthly]
Recruiting
-
Apr 2025 — Feb 2026 [monthly]
Recruiting
-
Feb 2025 — Apr 2025 [monthly]
Recruiting
-
Sep 2024 — Feb 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
▶ Show 8 earlier versions
-
Mar 2024 — Jul 2024 [monthly]
Not Yet Recruiting
-
Dec 2023 — Mar 2024 [monthly]
Not Yet Recruiting
-
Aug 2023 — Dec 2023 [monthly]
Not Yet Recruiting
-
Mar 2023 — Aug 2023 [monthly]
Not Yet Recruiting
-
Jul 2022 — Mar 2023 [monthly]
Not Yet Recruiting
-
May 2022 — Jul 2022 [monthly]
Not Yet Recruiting
-
Jan 2022 — May 2022 [monthly]
Not Yet Recruiting
-
Sep 2021 — Jan 2022 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Fondation Ophtalmologique Adolphe de Rothschild
For direct contact, visit the study record on ClinicalTrials.gov .